Share on LinkedInShare on LinkedIn

ARTICLE · 05 MAY 2022

Keeping Clean To Reduce M&A Antitrust Risk: Three Tips For Clean Teams During Due Diligence

Increased consolidation in the health care sector continues to draw media attention and antitrust scrutiny from a variety of regulators including the Federal Trade Commission, the Antitrust Division of the...

United StatesAntitrust/Competition Law

Increased consolidation in the health care sector continues to draw media attention and antitrust scrutiny from a variety of regulators including the Federal Trade Commission, the Antitrust Division of the Department of Justice and state attorneys general. As a result, health care providers and hospital systems which are considering mergers, acquisitions and other types of strategic partnerships or joint ventures should take steps to ensure that they do not violate antitrust laws when sharing information regarding the business case for a particular transaction and should also keep in mind that failing to close a transaction can turn a potential partner into a better-informed competitor. However, it is not always clear what information may be shared, or with whom. It is also difficult to know when a typical non-disclosure agreement may fall short of the desired protections. In general, the best practice is to establish guardrails around the diligence process

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from